The prostate cancer debate: pros & cons of screening and preventive drugs
Prostate cancer is the most common cancer in men, with over 40,000 new cases diagnosed in the UK every year. There is intense debate over whether men should undergo regular prostate-specific antigen (PSA) testing, as outlined in our previous blog post, and clinical trials have come to opposing conclusions about whether PSA screening saves lives… Read more »